Pectusin (Tablets) Instructions for Use

Instructions
Dosage forms

ATC Code

R07AX (Other drugs for the treatment of respiratory diseases)

Active Substances

Levomenthol (Rec.INN registered by WHO)

Eucalyptus oil (BP British Pharmacopoeia)

Clinical-Pharmacological Group

Herbal preparation with expectorant and antimicrobial action

Pharmacotherapeutic Group

Other drugs for the treatment of respiratory system diseases

Pharmacological Action

A combined herbal medicine. It exerts a local anti-inflammatory and antiseptic action.

Indications

Inflammatory diseases of the upper respiratory tract and pharynx including pharyngitis, laryngitis, and tracheitis.

Use the drug only for the conditions listed in the official prescribing information.

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
J02	Acute pharyngitis
J04	Acute laryngitis and tracheitis
J31.2	Chronic pharyngitis
J37	Chronic laryngitis and laryngotracheitis

ICD-11 code	Indication
CA02.Z	Acute pharyngitis, unspecified
CA05	Acute laryngitis or tracheitis
CA09.2	Chronic pharyngitis
CA0G	Chronic laryngitis or laryngotracheitis

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Apply the tablet topically by allowing it to dissolve slowly in the mouth.

Administer 1 to 4 times per day, with the exact frequency determined by the patient’s age and the severity of symptoms.

Follow the specific dosing instructions provided by a healthcare professional.

Adverse Reactions

Monitor for allergic reactions, which may include skin rash, itching, or urticaria.

Be aware that dyspeptic symptoms, such as nausea or stomach discomfort, occur rarely.

Discontinue use immediately and seek medical attention if any severe or persistent adverse effects develop.

Drug Interactions

Note that eucalyptus oil, a component of this preparation, has the potential to induce liver enzymes, specifically cytochrome P450.

This induction may lead to increased metabolism and reduced plasma concentrations of concurrently administered drugs that are substrates for these enzymes.

Exercise caution and monitor for potential decreased efficacy of other medications.

Contraindications

Do not use in patients with a known hypersensitivity to levomenthol, eucalyptus oil, or any other excipients in the formulation.
This drug is contraindicated in children under 8 years of age due to the risk of severe adverse reactions.

Assess patient history for these conditions prior to initiation of therapy.

Overdose

In case of accidental ingestion of a large number of tablets, expect symptoms related to the essential oil components, which may include gastrointestinal irritation, nausea, vomiting, and dizziness.

Initiate supportive and symptomatic care as there is no specific antidote.

Seek immediate medical attention or contact a poison control center for management advice.

Use in Pregnancy and Lactation

Use during pregnancy and breastfeeding is not recommended.

Pediatric Use

Use of the drug is contraindicated in children under 8 years of age.

Special Precautions

If symptoms of the disease persist or the condition worsens during use for 5 days, the patient should inform the attending physician.

Storage Conditions

Store at 2°C (36°F) to 15°C (59°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Pectusin [Vifitech, CJSC (Russia)]
Orally disintegrating tablets 4 mg+500 mcg: 10, 20, 30 or 50 pcs.

Marketing Authorization Holder

Vifitech, CJSC (Russia)

Dosage Form

Pectusin

Orally disintegrating tablets 4 mg+500 mcg: 10, 20, 30 or 50 pcs.

Dosage Form, Packaging, and Composition

Orally disintegrating tablets	1 tab.
Levomenthol	4 mg
Eucalyptus oil	500 mcg

10 pcs. – contour cell packaging.
10 pcs. – contour cell packaging (2) – cardboard packs.
10 pcs. – contour cell packaging (3) – cardboard packs.
10 pcs. – contour cell packaging (5) – cardboard packs.

Pectusin [Tatkhimpharmpreparaty, JSC (Russia)]
Orally disintegrating tablets 4 mg+500 mcg: 10 or 20 pcs.

Marketing Authorization Holder

Tatkhimpharmpreparaty, JSC (Russia)

Dosage Form

Pectusin

Orally disintegrating tablets 4 mg+500 mcg: 10 or 20 pcs.

Dosage Form, Packaging, and Composition

Orally disintegrating tablets	1 tab.
Levomenthol	4 mg
Eucalyptus oil	500 mcg

10 pcs. – contour cell packaging.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.

Pectusin [Technopharm LLC (Russia)]
Orally disintegrating tablets 4 mg+0.5 mg: 10, 20, 30, 40 or 50 pcs.

Marketing Authorization Holder

Technopharm LLC (Russia)

Manufactured By

Tatkhimpharmpreparaty, JSC (Russia)

Dosage Form

Pectusin

Orally disintegrating tablets 4 mg+0.5 mg: 10, 20, 30, 40 or 50 pcs.

Dosage Form, Packaging, and Composition

Orally disintegrating tablets white or almost white, round, flat-cylindrical, with a bevel and a score, with a characteristic smell of menthol and/or eucalyptus; marbling and inclusions of dark or light color are allowed on the surface of the tablets.

	1 tab.
Levomenthol	4 mg
Eucalyptus globulus leaf oil (eucalyptus oil)	0.5 mg

Excipients : sucrose, carmellose sodium (sodium carboxymethylcellulose), colloidal silicon dioxide (aerosil), β-cyclodextrin, talc, magnesium stearate.

10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
10 pcs. – contour cell packaging (3) – cardboard packs.
10 pcs. – contour cell packaging (4) – cardboard packs.
10 pcs. – contour cell packaging (5) – cardboard packs.

Pectusin [Pharmstandard-Lexredstva OJSC (Russia)]
Orally disintegrating tablets 4 mg+500 mcg: 10, 20 or 30 pcs.